Table of Contents 1 Market Overview 1.1 Choroidal Neovascularization Drug Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Choroidal Neovascularization Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 AVMOC-001 1.2.3 BB-3 1.2.4 BBT-007 1.2.5 DG-3 1.2.6 Entolimod 1.2.7 EWA-001 1.2.8 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Choroidal Neovascularization Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Overview of Global Choroidal Neovascularization Drug Market 1.4.1 Global Choroidal Neovascularization Drug Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Cellphire, Inc. 2.1.1 Cellphire, Inc. Details 2.1.2 Cellphire, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Cellphire, Inc. SWOT Analysis 2.1.4 Cellphire, Inc. Product and Services 2.1.5 Cellphire, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Humanetics Corporation 2.2.1 Humanetics Corporation Details 2.2.2 Humanetics Corporation Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Humanetics Corporation SWOT Analysis 2.2.4 Humanetics Corporation Product and Services 2.2.5 Humanetics Corporation Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Cumberland Pharmaceuticals, Inc. 2.3.1 Cumberland Pharmaceuticals, Inc. Details 2.3.2 Cumberland Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Cumberland Pharmaceuticals, Inc. SWOT Analysis 2.3.4 Cumberland Pharmaceuticals, Inc. Product and Services 2.3.5 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Chrysalis BioTherapeutics, Inc. 2.4.1 Chrysalis BioTherapeutics, Inc. Details 2.4.2 Chrysalis BioTherapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Chrysalis BioTherapeutics, Inc. SWOT Analysis 2.4.4 Chrysalis BioTherapeutics, Inc. Product and Services 2.4.5 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 GNI Group Ltd. 2.5.1 GNI Group Ltd. Details 2.5.2 GNI Group Ltd. Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 GNI Group Ltd. SWOT Analysis 2.5.4 GNI Group Ltd. Product and Services 2.5.5 GNI Group Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Cleveland BioLabs, Inc. 2.6.1 Cleveland BioLabs, Inc. Details 2.6.2 Cleveland BioLabs, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Cleveland BioLabs, Inc. SWOT Analysis 2.6.4 Cleveland BioLabs, Inc. Product and Services 2.6.5 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Meabco A/S 2.7.1 Meabco A/S Details 2.7.2 Meabco A/S Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Meabco A/S SWOT Analysis 2.7.4 Meabco A/S Product and Services 2.7.5 Meabco A/S Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 Eli Lilly and Company 2.8.1 Eli Lilly and Company Details 2.8.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Eli Lilly and Company SWOT Analysis 2.8.4 Eli Lilly and Company Product and Services 2.8.5 Eli Lilly and Company Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.9 Diffusion Pharmaceuticals Inc. 2.9.1 Diffusion Pharmaceuticals Inc. Details 2.9.2 Diffusion Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Diffusion Pharmaceuticals Inc. SWOT Analysis 2.9.4 Diffusion Pharmaceuticals Inc. Product and Services 2.9.5 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.10 INSYS Therapeutics, Inc. 2.10.1 INSYS Therapeutics, Inc. Details 2.10.2 INSYS Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 INSYS Therapeutics, Inc. SWOT Analysis 2.10.4 INSYS Therapeutics, Inc. Product and Services 2.10.5 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.11 ProCertus BioPharm Inc. 2.11.1 ProCertus BioPharm Inc. Details 2.11.2 ProCertus BioPharm Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 ProCertus BioPharm Inc. SWOT Analysis 2.11.4 ProCertus BioPharm Inc. Product and Services 2.11.5 ProCertus BioPharm Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.12 RxBio, Inc. 2.12.1 RxBio, Inc. Details 2.12.2 RxBio, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 RxBio, Inc. SWOT Analysis 2.12.4 RxBio, Inc. Product and Services 2.12.5 RxBio, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.13 Neumedicines Inc. 2.13.1 Neumedicines Inc. Details 2.13.2 Neumedicines Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 Neumedicines Inc. SWOT Analysis 2.13.4 Neumedicines Inc. Product and Services 2.13.5 Neumedicines Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.14 RDD Pharma Ltd. 2.14.1 RDD Pharma Ltd. Details 2.14.2 RDD Pharma Ltd. Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 RDD Pharma Ltd. SWOT Analysis 2.14.4 RDD Pharma Ltd. Product and Services 2.14.5 RDD Pharma Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.15 Pluristem Therapeutics Inc. 2.15.1 Pluristem Therapeutics Inc. Details 2.15.2 Pluristem Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Pluristem Therapeutics Inc. SWOT Analysis 2.15.4 Pluristem Therapeutics Inc. Product and Services 2.15.5 Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.16 Onconova Therapeutics, Inc. 2.16.1 Onconova Therapeutics, Inc. Details 2.16.2 Onconova Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.16.3 Onconova Therapeutics, Inc. SWOT Analysis 2.16.4 Onconova Therapeutics, Inc. Product and Services 2.16.5 Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.17 Soligenix, Inc. 2.17.1 Soligenix, Inc. Details 2.17.2 Soligenix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.17.3 Soligenix, Inc. SWOT Analysis 2.17.4 Soligenix, Inc. Product and Services 2.17.5 Soligenix, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.18 RedHill Biopharma Ltd. 2.18.1 RedHill Biopharma Ltd. Details 2.18.2 RedHill Biopharma Ltd. Major Business and Total Revenue (Financial Highlights) Analysis 2.18.3 RedHill Biopharma Ltd. SWOT Analysis 2.18.4 RedHill Biopharma Ltd. Product and Services 2.18.5 RedHill Biopharma Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.19 PharmaIN Corporation 2.19.1 PharmaIN Corporation Details 2.19.2 PharmaIN Corporation Major Business and Total Revenue (Financial Highlights) Analysis 2.19.3 PharmaIN Corporation SWOT Analysis 2.19.4 PharmaIN Corporation Product and Services 2.19.5 PharmaIN Corporation Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Choroidal Neovascularization Drug Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Choroidal Neovascularization Drug Manufacturer Market Share in 2019 3.3.2 Top 6 Choroidal Neovascularization Drug Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Choroidal Neovascularization Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Choroidal Neovascularization Drug Sales and Market Share by Regions (2015-2020) 4.1.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Regions (2015-2020) 4.2 North America Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 4.3 Europe Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 4.5 South America Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Choroidal Neovascularization Drug Sales, Revenue and Market Share by Country 5.1.1 North America Choroidal Neovascularization Drug Sales and Market Share by Country (2015-2020) 5.1.2 North America Choroidal Neovascularization Drug Revenue and Market Share by Country (2015-2020) 5.2 United States Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 5.3 Canada Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 5.4 Mexico Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Choroidal Neovascularization Drug Sales, Revenue and Market Share by Country 6.1.1 Europe Choroidal Neovascularization Drug Sales and Market Share by Country (2015-2020) 6.1.2 Europe Choroidal Neovascularization Drug Revenue and Market Share by Country (2015-2020) 6.2 Germany Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 6.3 UK Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 6.4 France Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 6.5 Russia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 6.6 Italy Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Choroidal Neovascularization Drug Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Choroidal Neovascularization Drug Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Choroidal Neovascularization Drug Revenue and Market Share by Regions (2015-2020) 7.2 China Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7.3 Japan Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7.4 Korea Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7.5 India Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 7.7 Australia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Choroidal Neovascularization Drug Sales, Revenue and Market Share by Country 8.1.1 South America Choroidal Neovascularization Drug Sales and Market Share by Country (2015-2020) 8.1.2 South America Choroidal Neovascularization Drug Revenue and Market Share by Country (2015-2020) 8.2 Brazil Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 8.3 Argentina Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Choroidal Neovascularization Drug Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Choroidal Neovascularization Drug Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Choroidal Neovascularization Drug Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 9.3 Turkey Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 9.4 Egypt Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 9.5 South Africa Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Choroidal Neovascularization Drug Sales and Market Share by Type (2015-2020) 10.2 Global Choroidal Neovascularization Drug Revenue and Market Share by Type (2015-2020) 10.3 Global Choroidal Neovascularization Drug Price by Type (2015-2020) 11 Global Choroidal Neovascularization Drug Market Segment by Application 11.1 Global Choroidal Neovascularization Drug Sales Market Share by Application (2015-2020) 11.2 Global Choroidal Neovascularization Drug Revenue Market Share by Application (2015-2020) 11.3 Global Choroidal Neovascularization Drug Price by Application (2015-2020) 12 Market Forecast 12.1 Global Choroidal Neovascularization Drug Sales, Revenue and Growth Rate (2021-2025) 12.2 Choroidal Neovascularization Drug Market Forecast by Regions (2021-2025) 12.2.1 North America Choroidal Neovascularization Drug Market Forecast (2021-2025) 12.2.2 Europe Choroidal Neovascularization Drug Market Forecast (2021-2025) 12.2.3 Asia-Pacific Choroidal Neovascularization Drug Market Forecast (2021-2025) 12.2.4 South America Choroidal Neovascularization Drug Market Forecast (2021-2025) 12.2.5 Middle East & Africa Choroidal Neovascularization Drug Market Forecast (2021-2025) 12.3 Choroidal Neovascularization Drug Market Forecast by Type (2021-2025) 12.3.1 Global Choroidal Neovascularization Drug Sales Forecast by Type (2021-2025) 12.3.2 Global Choroidal Neovascularization Drug Market Share Forecast by Type (2021-2025) 12.4 Choroidal Neovascularization Drug Market Forecast by Application (2021-2025) 12.4.1 Global Choroidal Neovascularization Drug Sales Forecast by Application (2021-2025) 12.4.2 Global Choroidal Neovascularization Drug Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Choroidal Neovascularization Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Choroidal Neovascularization Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Choroidal Neovascularization Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Cellphire, Inc. Basic Information, Manufacturing Base and Competitors Table 8. Cellphire, Inc. Choroidal Neovascularization Drug Major Business Table 9. Cellphire, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 10. Cellphire, Inc. SWOT Analysis Table 11. Cellphire, Inc. Choroidal Neovascularization Drug Product and Services Table 12. Cellphire, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Humanetics Corporation Basic Information, Manufacturing Base and Competitors Table 14. Humanetics Corporation Choroidal Neovascularization Drug Major Business Table 15. Humanetics Corporation Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 16. Humanetics Corporation SWOT Analysis Table 17. Humanetics Corporation Choroidal Neovascularization Drug Product and Services Table 18. Humanetics Corporation Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Cumberland Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table 20. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Major Business Table 21. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 22. Cumberland Pharmaceuticals, Inc. SWOT Analysis Table 23. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Product and Services Table 24. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Chrysalis BioTherapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table 26. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Major Business Table 27. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 28. Chrysalis BioTherapeutics, Inc. SWOT Analysis Table 29. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Product and Services Table 30. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. GNI Group Ltd. Basic Information, Manufacturing Base and Competitors Table 32. GNI Group Ltd. Choroidal Neovascularization Drug Major Business Table 33. GNI Group Ltd. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 34. GNI Group Ltd. SWOT Analysis Table 35. GNI Group Ltd. Choroidal Neovascularization Drug Product and Services Table 36. GNI Group Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Cleveland BioLabs, Inc. Basic Information, Manufacturing Base and Competitors Table 38. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Major Business Table 39. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 40. Cleveland BioLabs, Inc. SWOT Analysis Table 41. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Product and Services Table 42. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Meabco A/S Basic Information, Manufacturing Base and Competitors Table 44. Meabco A/S Choroidal Neovascularization Drug Major Business Table 45. Meabco A/S Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 46. Meabco A/S SWOT Analysis Table 47. Meabco A/S Choroidal Neovascularization Drug Product and Services Table 48. Meabco A/S Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table 50. Eli Lilly and Company Choroidal Neovascularization Drug Major Business Table 51. Eli Lilly and Company Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 52. Eli Lilly and Company SWOT Analysis Table 53. Eli Lilly and Company Choroidal Neovascularization Drug Product and Services Table 54. Eli Lilly and Company Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 55. Diffusion Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors Table 56. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Major Business Table 57. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 58. Diffusion Pharmaceuticals Inc. SWOT Analysis Table 59. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Product and Services Table 60. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 61. INSYS Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table 62. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Major Business Table 63. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 64. INSYS Therapeutics, Inc. SWOT Analysis Table 65. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Product and Services Table 66. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 67. ProCertus BioPharm Inc. Basic Information, Manufacturing Base and Competitors Table 68. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Major Business Table 69. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 70. ProCertus BioPharm Inc. SWOT Analysis Table 71. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Product and Services Table 72. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 73. RxBio, Inc. Basic Information, Manufacturing Base and Competitors Table 74. RxBio, Inc. Choroidal Neovascularization Drug Major Business Table 75. RxBio, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 76. RxBio, Inc. SWOT Analysis Table 77. RxBio, Inc. Choroidal Neovascularization Drug Product and Services Table 78. RxBio, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 79. Neumedicines Inc. Basic Information, Manufacturing Base and Competitors Table 80. Neumedicines Inc. Choroidal Neovascularization Drug Major Business Table 81. Neumedicines Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 82. Neumedicines Inc. SWOT Analysis Table 83. Neumedicines Inc. Choroidal Neovascularization Drug Product and Services Table 84. Neumedicines Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 85. RDD Pharma Ltd. Basic Information, Manufacturing Base and Competitors Table 86. RDD Pharma Ltd. Choroidal Neovascularization Drug Major Business Table 87. RDD Pharma Ltd. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 88. RDD Pharma Ltd. SWOT Analysis Table 89. RDD Pharma Ltd. Choroidal Neovascularization Drug Product and Services Table 90. RDD Pharma Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 91. Pluristem Therapeutics Inc. Basic Information, Manufacturing Base and Competitors Table 92. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Major Business Table 93. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 94. Pluristem Therapeutics Inc. SWOT Analysis Table 95. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Product and Services Table 96. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 97. Onconova Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table 98. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Major Business Table 99. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 100. Onconova Therapeutics, Inc. SWOT Analysis Table 101. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Product and Services Table 102. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 103. Soligenix, Inc. Basic Information, Manufacturing Base and Competitors Table 104. Soligenix, Inc. Choroidal Neovascularization Drug Major Business Table 105. Soligenix, Inc. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 106. Soligenix, Inc. SWOT Analysis Table 107. Soligenix, Inc. Choroidal Neovascularization Drug Product and Services Table 108. Soligenix, Inc. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 109. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Type and Application Table 110. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Major Business Table 111. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 112. RedHill Biopharma Ltd. SWOT Analysis Table 113. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Product and Services Table 114. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 115. PharmaIN Corporation Basic Information, Manufacturing Base and Competitors Table 116. PharmaIN Corporation Choroidal Neovascularization Drug Major Business Table 117. PharmaIN Corporation Choroidal Neovascularization Drug Total Revenue (USD Million) (2017-2018) Table 118. PharmaIN Corporation SWOT Analysis Table 119. PharmaIN Corporation Choroidal Neovascularization Drug Product and Services Table 120. PharmaIN Corporation Choroidal Neovascularization Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 121. Global Choroidal Neovascularization Drug Sales by Manufacturer (2018-2019) (K Pcs) Table 122. Global Choroidal Neovascularization Drug Revenue by Manufacturer (2018-2019) (USD Million) Table 123. Global Choroidal Neovascularization Drug Sales by Regions (2015-2020) (K Pcs) Table 124. Global Choroidal Neovascularization Drug Sales Market Share by Regions (2015-2020) Table 125. Global Choroidal Neovascularization Drug Revenue by Regions (2015-2020) (USD Million) Table 126. North America Choroidal Neovascularization Drug Sales by Countries (2015-2020) (K Pcs) Table 127. North America Choroidal Neovascularization Drug Sales Market Share by Countries (2015-2020) Table 128. North America Choroidal Neovascularization Drug Revenue by Countries (2015-2020) (USD Million) Table 129. North America Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) Table 130. Europe Choroidal Neovascularization Drug Sales by Countries (2015-2020) (K Pcs) Table 131. Europe Choroidal Neovascularization Drug Sales Market Share by Countries (2015-2020) Table 132. Europe Choroidal Neovascularization Drug Revenue by Countries (2015-2020) (USD Million) Table 133. Asia-Pacific Choroidal Neovascularization Drug Sales by Regions (2015-2020) (K Pcs) Table 134. Asia-Pacific Choroidal Neovascularization Drug Sales Market Share by Regions (2015-2020) Table 135. Asia-Pacific Choroidal Neovascularization Drug Revenue by Regions (2015-2020) (USD Million) Table 136. South America Choroidal Neovascularization Drug Sales by Countries (2015-2020) (K Pcs) Table 137. South America Choroidal Neovascularization Drug Sales Market Share by Countries (2015-2020) Table 138. South America Choroidal Neovascularization Drug Revenue by Countries (2015-2020) (USD Million) Table 139. South America Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) Table 140. Middle East & Africa Choroidal Neovascularization Drug Sales by Countries (2015-2020) (K Pcs) Table 141. Middle East & Africa Choroidal Neovascularization Drug Sales Market Share by Countries (2015-2020) Table 142. Middle East & Africa Choroidal Neovascularization Drug Revenue by Countries (2015-2020) (USD Million) Table 143. Middle East & Africa Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) Table 144. Global Choroidal Neovascularization Drug Sales by Type (2015-2020) (K Pcs) Table 145. Global Choroidal Neovascularization Drug Sales Share by Type (2015-2020) Table 146. Global Choroidal Neovascularization Drug Revenue by Type (2015-2020) (USD Million) Table 147. Global Choroidal Neovascularization Drug Revenue Share by Type (2015-2020) Table 148. Global Choroidal Neovascularization Drug Sales by Application (2015-2020) (K Pcs) Table 149. Global Choroidal Neovascularization Drug Sales Share by Application (2015-2020) Table 150. Global Choroidal Neovascularization Drug Sales Forecast by Regions (2021-2025) (K Pcs) Table 151. Global Choroidal Neovascularization Drug Market Share Forecast by Regions (2021-2025) Table 152. Global Choroidal Neovascularization Drug Sales Forecast by Type (2021-2025) (K Pcs) Table 153. Global Choroidal Neovascularization Drug Market Share Forecast by Type (2021-2025) Table 154. Global Choroidal Neovascularization Drug Sales Forecast by Application (2021-2025) Table 155. Global Choroidal Neovascularization Drug Market Share Forecast by Application (2021-2025) Table 156. Direct Channel Pros & Cons Table 157. Indirect Channel Pros & Cons Table 158. Distributors/Traders/ Dealers List List of Figures Figure 1. Choroidal Neovascularization Drug Picture Figure 2. Global Sales Market Share of Choroidal Neovascularization Drug by Type in 2019 Figure 3. AVMOC-001 Picture Figure 4. BB-3 Picture Figure 5. BBT-007 Picture Figure 6. DG-3 Picture Figure 7. Entolimod Picture Figure 8. EWA-001 Picture Figure 9. Others Picture Figure 10. Choroidal Neovascularization Drug Sales Market Share by Application in 2018 Figure 11. Clinic Picture Figure 12. Hospital Picture Figure 13. Others Picture Figure 14. Global Choroidal Neovascularization Drug Market Status and Outlook (2015-2025) (USD Million) Figure 15. United States Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 16. Canada Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 17. Mexico Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 18. Germany Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 19. France Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 20. UK Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 21. Russia Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 22. Italy Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 23. China Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 24. Japan Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 25. Korea Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 26. India Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 27. Southeast Asia Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 28. Australia Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 29. Brazil Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 30. Egypt Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 31. Saudi Arabia Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 32. South Africa Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 33. Turkey Choroidal Neovascularization Drug Revenue (Value) and Growth Rate (2015-2025) Figure 34. Global Choroidal Neovascularization Drug Sales Market Share by Manufacturer in 2019 Figure 35. Global Choroidal Neovascularization Drug Revenue Market Share by Manufacturer in 2019 Figure 36. Top 3 Choroidal Neovascularization Drug Manufacturer (Revenue) Market Share in 2019 Figure 37. Top 6 Choroidal Neovascularization Drug Manufacturer (Revenue) Market Share in 2019 Figure 38. Key Manufacturer Market Share Trend Figure 39. Global Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 40. Global Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 41. Global Choroidal Neovascularization Drug Revenue Market Share by Regions (2015-2020) Figure 42. Global Choroidal Neovascularization Drug Revenue Market Share by Regions in 2018 Figure 43. North America Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) Figure 44. Europe Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) Figure 45. Asia-Pacific Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) Figure 46. South America Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) Figure 47. Middle East & Africa Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) Figure 48. North America Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 49. North America Choroidal Neovascularization Drug Sales Market Share by Countries (2015-2020) Figure 50. North America Choroidal Neovascularization Drug Sales Market Share by Countries in 2018 Figure 51. North America Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) (USD Million) Figure 52. North America Choroidal Neovascularization Drug Revenue Market Share by Countries in 2018 Figure 53. United States Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 54. Canada Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 55. Mexico Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 56. Europe Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 57. Europe Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) Figure 58. Europe Choroidal Neovascularization Drug Revenue Market Share by Countries in 2019 Figure 59. Germany Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 60. UK Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 61. France Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 62. Russia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 63. Italy Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 64. Asia-Pacific Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 65. Asia-Pacific Choroidal Neovascularization Drug Sales Market Share by Regions 2019 Figure 66. Asia-Pacific Choroidal Neovascularization Drug Revenue Market Share by Regions 2019 Figure 67. China Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 68. Japan Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 69. Korea Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 70. India Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 71. Southeast Asia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 72. South America Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 73. South America Choroidal Neovascularization Drug Sales Market Share by Countries in 2019 Figure 74. South America Choroidal Neovascularization Drug Revenue Market Share by Countries in 2019 Figure 75. Brazil Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 76. Argentina Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 77. Middle East and Africa Choroidal Neovascularization Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 78. Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by Countries in 2019 Figure 79. Middle East and Africa Choroidal Neovascularization Drug Revenue Market Share by Countries (2015-2020) Figure 80. Middle East and Africa Choroidal Neovascularization Drug Revenue Market Share by Countries in 2019 Figure 81. Saudi Arabia Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 82. Egypt Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 83. Turkey Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 84. South Africa Choroidal Neovascularization Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 85. Global Choroidal Neovascularization Drug Sales and Growth Rate (2021-2025) (K Pcs) Figure 86. Global Choroidal Neovascularization Drug Revenue and Growth Rate (2021-2025) (USD Million) Figure 87. North America Sales Choroidal Neovascularization Drug Market Forecast (2021-2025) (K Pcs) Figure 88. Europe Sales Choroidal Neovascularization Drug Market Forecast (2021-2025) (K Pcs) Figure 89. Asia-Pacific Sales Choroidal Neovascularization Drug Market Forecast (2021-2025) (K Pcs) Figure 90. South America Sales Choroidal Neovascularization Drug Market Forecast (2021-2025) (K Pcs) Figure 91. Middle East & Africa Sales Choroidal Neovascularization Drug Market Forecast (2021-2025) (K Pcs) Figure 92. Sales Channel: Direct Channel vs Indirect Channel

Cellphire, Inc. Humanetics Corporation Cumberland Pharmaceuticals, Inc. Chrysalis BioTherapeutics, Inc. GNI Group Ltd. Cleveland BioLabs, Inc. Meabco A/S Eli Lilly and Company Diffusion Pharmaceuticals Inc. INSYS Therapeutics, Inc. ProCertus BioPharm Inc. RxBio, Inc. Neumedicines Inc. RDD Pharma Ltd. Pluristem Therapeutics Inc. Onconova Therapeutics, Inc. Soligenix, Inc. RedHill Biopharma Ltd. PharmaIN Corporation